{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:04:59Z","timestamp":1781103899352,"version":"3.54.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>This study aimed to assess the correlation between serum concentration of 25-hydroxyvitamin D and albuminuria progression of diabetic kidney disease (DKD) and to use bioinformatics methods to determine the potential mechanism in the pathological process of advanced DKD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 178 type 1 diabetes mellitus (T1DM) patients with microalbuminuria complications who were hospitalized at least twice (with an interval &amp;gt; 24 months) in the Department of Endocrinology of The First Affiliated Hospital of USTC were included in this study. According to the urinary albumin creatinine ratio (UACR), we classified DKD stages as follows: microalbuminuria (UACR, 30-300 mg\/g), and macroalbuminuria (UACR, &amp;gt;300 mg\/g). We divided the patients into DKD progression (N=44) and stable group (N=134) on account of urinary albumin-to-creatinine ratio (UACR) by at least two randomized measurements. Stable group was defined as UACR between 30 and 300 mg\/g, whereas progression group was defined as UACR &amp;gt;300 mg\/g at the end of follow-up. Data were obtained from participants\u2019 medical records, and the 25-hydroxyvitamin D level was categorized into three groups as follows: G1 (N=45), &amp;lt;10 ng\/mL; G2 (N=80), 10-20 ng\/ml; and G3 (N=53), \u226520 ng\/mL. The Nephroseq database (<jats:uri>http:\/\/v5.nephroseq.org<\/jats:uri>) was used to identify VDR expression in diabetic nephropathy. The dataset GSE142025 from GEO (<jats:uri>http:\/\/www.ncbi.nlm.nih.gov\/geo<\/jats:uri>) was downloaded. After stratification by the median-centered log2 VDR expression value, the 21 advanced DKD samples were divided into two groups (low VDR expression group and high VDR expression group). Gene set enrichment analysis (GSEA) (<jats:uri>http:\/\/software.broadinstitute.org\/gsea\/index.jsp<\/jats:uri>). Differentially expressed genes (DEGs) were screened by the limma package (adjusted p &amp;lt; 0.05, |logFC| &amp;gt; 1). The Gene Ontology (GO; <jats:uri>http:\/\/www.geneontology.org\/<\/jats:uri>) database and pathway analysis within the Kyoto Encyclopedia of Genes and Genomes (KEGG; <jats:uri>https:\/\/www.kegg.jp\/<\/jats:uri>) were performed using the R package ClusterProfile. The CIBERSORT (Cell type Identification By Estimating Relative Subsets Of known RNA Transcripts) algorithm was utilized for calculating the infiltrated immune cells in advanced kidney tissues.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>1) A multivariate Cox regression analysis revealed that DR (diabetic retinopathy), eGFR (estimated glomerular filtration rate), and 25-hydroxyvitamin D were significant independent predictors of DKD progression (HR: 2.57, 95% CI: 1.44.4.24, p=0.007; HR: 2.13, 95% CI: 1.58.3.79, p = 0.011; HR: 0.732, 95% CI: 0.232\u20130.816, p = 0.023, respectively). 2) Kaplan\u2013Meier survival curves of DKD progression by serum 25-hydroxyvitamin D stratification showed that the G2 and G3 groups were significantly different when compared with the G1 group (log-rank \u03c72 = 14.69, p &amp;lt;0.001; \u03c72 = 28.26, p &amp;lt;0.001, respectively). 3) There was a weak negative correlation between 25-hydroxyvitamin D level and UACR at baseline,and the overall mean rate of change in eGFR was 1.121 \u00b1 0.19 ml\/min\/1.73 m2\/year. Neither crude nor adjusted rate of decline in eGFR was significantly different among patients classified according to baseline serum 25-hydroxyvitamin D levels (all p&amp;lt;0.05). 4) The high expression of VDR group was most positively correlated with enriched gene sets like reactome innate immune system and reactome G alpha I signaling events when compared with the low expression of VDR group. 5) The CIBERSORT algorithm showed decreased M2 macrophage infiltration in advanced kidneys in comparison to low VDR expression and high VDR expression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study concluded that low 25-hydroxyvitamin D levels can predict an increased risk of DKD albuminuria progression and eGFR decline. Decreased M2 macrophage infiltration may be a potential mechanism involved in this pathogenesis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.880930","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T06:57:42Z","timestamp":1652338662000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Correlation Between Serum 25-Hydroxyvitamin D Levels in Albuminuria Progression of Diabetic Kidney Disease and Underlying Mechanisms By Bioinformatics Analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Bin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shandong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2018.10.005","article-title":"Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013","volume":"73","author":"Koye","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13743","article-title":"Type 2 Diabetes and the Kidney: Insights From Cardiovascular Outcome Trials","volume":"21","author":"Giugliano","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014090947","article-title":"Normal 25-Hydroxyvitamin D Levels Are Associated With Less Proteinuria and Attenuate Renal Failure Progression in Children With CKD","volume":"27","author":"Shroff","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1925424","DOI":"10.1155\/2016\/1925424","article-title":"Levels of Serum 25(OH)VD3, HIF-1\u03b1, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients With Different Urine Albumin Creatinine Ratio","volume":"2016","author":"Shao","year":"2016","journal-title":"J Diabetes Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00199","article-title":"Albuminuria Reduction After High Dose of Vitamin D in Patients With Type 1 Diabetes Mellitus: A Pilot Study","volume":"8","author":"Felicio","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-020-0286-5","article-title":"Integrated Multiomics Approaches to Improve Classification of Chronic Kidney Disease","volume":"16","author":"Eddy","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102","article-title":"Gene Set Enrichment Analysis: A Knowledge-Based Approach for Interpreting Genome-Wide Expression Profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1055","article-title":"The Gene Ontology Resource: 20 Years and Still GOing Strong","volume":"47","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: New Perspectives on Genomes, Pathways, Diseases and Drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust Enumeration of Cell Subsets From Tissue Expression Profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2016.105","article-title":"Diabetes Mellitus Statistics on Prevalence and Mortality: Facts and Fallacies","volume":"12","author":"Zimmet","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/1110-9165.197379","article-title":"Diabetic Kidney Disease: Worldwide Difference of Prevalence and Risk Factors","volume":"5","author":"Gheith","year":"2016","journal-title":"J\u00a0Nephropharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1900\/RDS.2018.15.26","article-title":"Management of Type 2 Diabetes and Chronic Kidney Disease in Fiji in 2018: Knowledge, Attitude, and Practice of Patients","volume":"15","author":"Alvis","year":"2019","journal-title":"Rev Diabetes Stud"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162554","article-title":"Vitamin D Deficiency and Glycemic Status in Children and Adolescents With Type 1 Diabetes Mellitus","volume":"11","author":"Savastio","year":"2016","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.diabres.2016.04.049","article-title":"The Role of Mineral and Bone Disorders in the Development and Progression of Cardiac and Renal Pathology in Patients With Type 1 Diabetes Mellitus of Long Duration","volume":"118","author":"Biragova","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/nrendo.2012.227","article-title":"Diabetes: Effect of Vitamin D on Diabetic Kidney Disease in T1DM","volume":"9","author":"Rossing","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2014.12.008","article-title":"Lower Serum 25 (OH) D Concentrations in Type 1 Diabetes: A Meta-Analysis","volume":"108","author":"Feng","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.3390\/nu12092518","article-title":"High-Dose Vitamin D Supplementation Improves Microcirculation and Reduces Inflammation in Diabetic Neuropathy Patients","volume":"12","author":"Karonova","year":"2020","journal-title":"Nutrients"},{"key":"B19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/nu9030307","article-title":"The Association Between Vitamin D Deficiency and Diabetic Retinopathy in Type 2 Diabetes: A Meta-Analysis of Observational Studies","volume":"9","author":"Luo","year":"2017","journal-title":"Nutrients"},{"key":"B20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/jrms.JRMS_303_18","article-title":"Vitamin D Deficiency Increases Risk of Nephropathy and Cardiovascular Diseases in Type 2 Diabetes Mellitus Patients","volume":"24","author":"Aljack","year":"2019","journal-title":"J Res Med Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2042018820930904","DOI":"10.1177\/2042018820930904","article-title":"Lower Serum 25-Hydroxyvitamin D Levels Are Associated With Impaired Glomerular Filtration Rate in Type 2 Diabetes Patients","volume":"11","author":"Dall'Agnol","year":"2020","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"107665","DOI":"10.1016\/j.jdiacomp.2020.107665","article-title":"Assessment of Urinary NGAL for Differential Diagnosis and Progression of Diabetic Kidney Disease","volume":"34","author":"Duan","year":"2020","journal-title":"J Diabetes Complications"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2852","article-title":"Circulating Vitamin D Metabolites and Kidney Disease in Type 1 Diabetes","volume":"97","author":"de Boer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00910113","article-title":"25 (OH) Vitamin D Levels and Renal Disease Progression in Patients With Type 2 Diabetic Nephropathy and Blockade of the Renin-Angiotensin System","volume":"8","author":"Fernandez-Juarez","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12933-015-0231-2","article-title":"Low 25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 Levels Are Independently Associated With Macroalbuminuria, But Not With Retinopathy and Macrovascular Disease in Type 1 Diabetes: The EURODIAB Prospective Complications Study","volume":"14","author":"Engelen","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2018.180401","article-title":"Association of Circulating Vitamin D, VDBP, and Vitamin D Receptor Expression With Severity of Diabetic Nephropathy in a Group of Saudi Type 2 Diabetes Mellitus Patients","volume":"64","author":"Fawzy","year":"2018","journal-title":"Clin Lab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2019-0015","article-title":"Associations Between Vitamin D and Microvascular Complications in Middle-Aged and Elderly Diabetic Patients","volume":"25","author":"Wan","year":"2019","journal-title":"Endocr Pract"},{"key":"B28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40200-015-0186-6","article-title":"Vitamin D & Its Analogues in Type 2 Diabetic Nephropathy: A Systematic Review","volume":"14","author":"Chokhandre","year":"2015","journal-title":"J\u00a0Diabetes Metab Disord"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu404","article-title":"Vitamin D Analogues to Target Residual Proteinuria: Potential Impact on Cardiorenal Outcomes","volume":"30","author":"Humalda","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjms.2018.12.005","article-title":"Role of Vitamin D and Its Analogues in Diabetic Nephropathy: A Meta-Analysis","volume":"357","author":"Gupta","year":"2019","journal-title":"Am J Med Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1038\/s41598-019-40049-z","article-title":"Correlations Among Diabetic Microvascular Complications: A Systematic Review and Meta-Analysis","volume":"9","author":"Li","year":"2019","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.148619","article-title":"Plasma 25-Hydroxyvitamin D and Regulation of the Renin-Angiotensin System in Humans","volume":"55","author":"Forman","year":"2010","journal-title":"Hypertension"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2010.05.037","article-title":"Independent Association Between 1,25-Dihydroxyvitamin D, 25-Hydroxyvitamin D and the Renin-Angiotensin System: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study","volume":"411","author":"Tomaschitz","year":"2010","journal-title":"Clin Chim Acta"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.10343","article-title":"Vitamin D Regulation of the Renin-Angiotensin System","volume":"88","author":"Li","year":"2003","journal-title":"J Cell Biochem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-015-0414-4","article-title":"Vitamin D Improves Diabetic Nephropathy in Rats by Inhibiting Renin and Relieving Oxidative Stress","volume":"39","author":"Deng","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.69","article-title":"Paricalcitol Attenuates Cyclosporine-Induced Kidney Injury in Rats","volume":"77","author":"Park","year":"2010","journal-title":"Kidney Int"},{"key":"B37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/sj.ki.5002296","article-title":"1,25-Dihydroxyvitamin D3 Targeting of NF-kappaB Suppresses High Glucose-Induced MCP-1 Expression in Mesangial Cells","volume":"72","author":"Zhang","year":"2007","journal-title":"Kidney Int"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4137268","DOI":"10.1155\/2020\/4137268","article-title":"The Emerging Role of Vitamin D and Vitamin D Receptor in Diabetic Nephropathy","volume":"2020","author":"Lei","year":"2020","journal-title":"BioMed Res Int"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13983","article-title":"Exploring Macrophage Cell Therapy on Diabetic Kidney Disease","volume":"23","author":"Guiteras","year":"2019","journal-title":"J Cell Mol Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.880930\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T06:57:45Z","timestamp":1652338665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.880930\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":39,"alternative-id":["10.3389\/fendo.2022.880930"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.880930","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"article-number":"880930"}}